Market Cap : 6.88 M | Enterprise Value : 6.75 M | P/E (TTM) : | P/B : |
---|
OTCPK:ICOTF has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
OTCPK:ICOTF has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
iCo Therapeutics's Notes Receivable for the quarter that ended in Sep. 2020 was $0.00 Mil.
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.
No Headline